Evidence map›Paper›PMID 35355019›Full record

ArticleNature2022

N

Idálio J Viegas, Juan Pereira de Macedo, Lúcia Serra, Mariana De Niz, Adriana Temporão, Sara Silva Pereira, Aashiq H Mirza, Ed Bergstrom, João A Rodrigues, Francisco Aresta-Branco and 2 more

Open access · greenAbstract read
In one paragraph

Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. NResearch (Washington, D.C.) · 2026
    Article
  10. Nanopore-mFrontiers in genetics · 2026
    Article
  11. Review
  12. Poly(A) tail regulation in stem cells and early development.Cell regeneration (London, England) · 2025
    Review
  13. Article
  14. RNA modification is the mark and strategy for host-microbe interactions.Cellular and molecular life sciences : CMLS · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Research progress of mosquito-borne virus mRNA vaccines.Molecular therapy. Methods & clinical development · 2025
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 4 countries.

Idálio J ViegasInstituto de Medicina Molecular-João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Juan Pereira de Macedo *Instituto de Medicina Molecular-João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Lúcia Serra *Instituto de Medicina Molecular-João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Mariana De NizInstituto de Medicina Molecular-João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.ORCID http://orcid.org/0000-0001-6987-6789
Adriana TemporãoInstituto de Medicina Molecular-João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.ORCID http://orcid.org/0000-0002-1208-9984
Sara Silva PereiraInstituto de Medicina Molecular-João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Aashiq H MirzaDepartment of Pharmacology, Weill Medical College, Cornell University, New York, NY, USA.
Ed BergstromDepartment of Chemistry, University of York, York, UK.
João A RodriguesInstituto de Medicina Molecular-João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Francisco Aresta-BrancoInstituto de Medicina Molecular-João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.
Samie R JaffreyDepartment of Pharmacology, Weill Medical College, Cornell University, New York, NY, USA.ORCID http://orcid.org/0000-0003-3615-6958
Luisa M FigueiredoInstituto de Medicina Molecular-João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal. lmf@medicina.ulisboa.pt.ORCID http://orcid.org/0000-0002-5752-6586
University of Lisbon · PTCornell University · USUniversity of York · GB

Funding

CANCER PHARMACOLOGYT32CA062948 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI LORRAINE J GUDAS · 1994 to 2026
$12.1M
New mechanisms and technologies for understanding post-transcriptional gene regulation in neuronsR35NS111631 · NINDS · WEILL MEDICAL COLL OF CORNELL UNIV · PI SAMIE R JAFFREY · 2019 to 2026
$8.6M
NCI NIH HHS T32 CA062948NINDS NIH HHS R35 NS111631
6 · The paper itself

Abstract

RNA modifications are important regulators of gene expression

Indexed as

RNA Processing, Post-TranscriptionalTrypanosoma brucei bruceiVariant Surface Glycoproteins, Trypanosoma3' Untranslated RegionsAdenosineGene Expression RegulationRNARNA, MessengerTranscription, Genetic3' Untranslated RegionsAdenosineN-methyladenosineRNARNA, MessengerVariant Surface Glycoproteins, Trypanosoma

Identifiers

PMID35355019
PMCPMC9150445
OpenAlexW4220773262

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.